Silvercrest Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.3M | Sell |
313,984
-14,780
| -4% | -$801K | 0.13% | 215 |
|
|
2025
Q4 | $16.1M | Hold |
328,764
| – | – | 0.11% | 241 |
|
|
2025
Q3 | $14.2M | Sell |
328,764
-600
| -0.2% | -$23.4K | 0.09% | 261 |
|
|
2025
Q2 | $12.6M | Sell |
329,364
-2,715
| -0.8% | -$104K | 0.09% | 279 |
|
|
2025
Q1 | $12.9M | Buy |
332,079
+2,479
| +0.8% | +$90.8K | 0.09% | 258 |
|
|
2024
Q4 | $11.1M | Sell |
329,600
-1,388
| -0.4% | -$50K | 0.07% | 277 |
|
|
2024
Q3 | $13.5M | Sell |
330,988
-326
| -0.1% | -$13.3K | 0.09% | 224 |
|
|
2024
Q2 | $12.8M | Hold |
331,314
| – | – | 0.09% | 230 |
|
|
2024
Q1 | $14.2M | Hold |
331,314
| – | – | 0.1% | 216 |
|
|
2023
Q4 | $12.3M | Buy |
331,314
+764
| +0.2% | +$27.4K | 0.09% | 222 |
|
|
2023
Q3 | $12M | Hold |
330,550
| – | – | 0.09% | 212 |
|
|
2023
Q2 | $11.8M | Buy |
330,550
+950
| +0.3% | +$34.1K | 0.08% | 219 |
|
|
2023
Q1 | $11.7M | Hold |
329,600
| – | – | 0.09% | 214 |
|
|
2022
Q4 | $11.6M | Sell |
329,600
-2,360
| -0.7% | -$78.6K | 0.09% | 205 |
|
|
2022
Q3 | $9.77M | Sell |
331,960
-2
| -0% | -$76 | 0.08% | 227 |
|
|
2022
Q2 | $18.1M | Sell |
331,962
-3
| -0% | -$166 | 0.14% | 174 |
|
|
2022
Q1 | $18.1M | Sell |
331,965
-2,757
| -0.8% | -$150K | 0.12% | 192 |
|
|
2021
Q4 | $18.5M | Sell |
334,722
-2,248
| -0.7% | -$117K | 0.12% | 188 |
|
|
2021
Q3 | $16.1M | Sell |
336,970
-35,080
| -9% | -$1.76M | 0.11% | 199 |
|
|
2021
Q2 | $18.5M | Sell |
372,050
-3,120
| -0.8% | -$150K | 0.12% | 193 |
|
|
2021
Q1 | $16.7M | Sell |
375,170
-912
| -0.2% | -$41.4K | 0.11% | 200 |
|
|
2020
Q4 | $17.3M | Sell |
376,082
-52,297
| -12% | -$2.4M | 0.13% | 182 |
|
|
2020
Q3 | $20.2M | Sell |
428,379
-471
| -0.1% | -$23.6K | 0.17% | 153 |
|
|
2020
Q2 | $21.9M | Hold |
428,850
| – | – | 0.19% | 140 |
|
|
2020
Q1 | $20.3M | Sell |
428,850
-2,160
| -0.5% | -$115K | 0.22% | 129 |
|
|
2019
Q4 | $25.3M | Sell |
431,010
-7,680
| -2% | -$427K | 0.2% | 135 |
|
|
2019
Q3 | $23.4M | Hold |
438,690
| – | – | 0.19% | 134 |
|
|
2019
Q2 | $21.9M | Sell |
438,690
-1,164
| -0.3% | -$58.4K | 0.21% | 138 |
|
|
2019
Q1 | $23M | Sell |
439,854
-115
| -0% | -$5.75K | 0.23% | 134 |
|
|
2018
Q4 | $21M | Sell |
439,969
-41,390
| -9% | -$2.04M | 0.23% | 132 |
|
|
2018
Q3 | $24.2M | Sell |
481,359
-42,591
| -8% | -$2.16M | 0.22% | 135 |
|
|
2018
Q2 | $26.4M | Buy |
523,950
+580
| +0.1% | +$29.2K | 0.25% | 131 |
|
|
2018
Q1 | $25.6M | Buy |
523,370
+80
| +0% | +$3.73K | 0.25% | 129 |
|
|
2017
Q4 | $23.2M | Sell |
523,290
-9,008
| -2% | -$416K | 0.22% | 134 |
|
|
2017
Q3 | $27M | Sell |
532,298
-35
| -0% | -$1.78K | 0.27% | 122 |
|
|
2017
Q2 | $28.7M | Sell |
532,333
-1,190
| -0.2% | -$63.4K | 0.31% | 115 |
|
|
2017
Q1 | $28.1M | Buy |
533,523
+80
| +0% | +$4.06K | 0.3% | 109 |
|
|
2016
Q4 | $25.7M | Sell |
533,443
-1,440
| -0.3% | -$71.1K | 0.29% | 112 |
|
|
2016
Q3 | $28.8M | Hold |
534,883
| – | – | 0.35% | 101 |
|
|
2016
Q2 | $29M | Buy |
534,883
+3,900
| +0.7% | +$205K | 0.37% | 100 |
|
|
2016
Q1 | $26.9M | Sell |
530,983
-141,280
| -21% | -$7.04M | 0.37% | 98 |
|
|
2015
Q4 | $33.9M | Hold |
672,263
| – | – | 0.47% | 87 |
|
|
2015
Q3 | $32.3M | Sell |
672,263
-720
| -0.1% | -$37.5K | 0.49% | 88 |
|
|
2015
Q2 | $35M | Hold |
672,983
| – | – | 0.47% | 85 |
|
|
2015
Q1 | $38.8M | Buy |
672,983
+4,697
| +0.7% | +$269K | 0.55% | 69 |
|
|
2014
Q4 | $35.7M | Sell |
668,286
-1,057
| -0.2% | -$59.1K | 0.52% | 66 |
|
|
2014
Q3 | $38.5M | Sell |
669,343
-240,136
| -26% | -$14.7M | 0.59% | 55 |
|
|
2014
Q2 | $60.8M | Sell |
909,479
-1,255
| -0.1% | -$84.9K | 0.91% | 28 |
|
|
2014
Q1 | $60.8M | Hold |
910,734
| – | – | 0.97% | 28 |
|
|
2013
Q4 | $60.8M | Sell |
910,734
-1,024
| -0.1% | -$66.4K | 1.01% | 22 |
|
|
2013
Q3 | $57.2M | Sell |
911,758
-76,649
| -8% | -$4.93M | 1.1% | 19 |
|
|
2013
Q2 | $61.7M | Buy |
+988,407
| New | +$62.7M | 1.3% | 13 |
|
Other funds holding GSK
JEST
Silvercrest Asset Management's GSK Position: Q1 2026 in Review
Silvercrest Asset Management reduced its GSK (GSK) stake by 4.5% in Q1 2026, selling an estimated $801K and leaving 313,984 shares worth $17.3M. The position accounts for 0.13% of the portfolio, ranked #215.
Silvercrest Asset Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.7M in Q2 2013. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Silvercrest Asset Management held 313,984 shares of GSK worth $17.3M as of Q1 2026.
- Silvercrest Asset Management sold 14,780 GSK shares in Q1 2026, an estimated $801K.
- GSK made up 0.13% of Silvercrest Asset Management's portfolio in Q1 2026, its #215 holding.
- Silvercrest Asset Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Silvercrest Asset Management's GSK position peaked at $61.7M in Q2 2013.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.